comparemela.com

Page 2 - Acrivon Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sands Capital raises $555M fund amid upturn in biotech crossover investing

Sands Capital raises $555M fund amid upturn in biotech crossover investing
biopharmadive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biopharmadive.com Daily Mail and Mail on Sunday newspapers.

ACRV Stock Earnings: Acrivon Therapeutics Beats EPS for Q1 2024

ACRV Stock Earnings: Acrivon Therapeutics Beats EPS for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Acrivon Therapeutics (NASDAQ:ACRV) Cut to Neutral at LADENBURG THALM/SH SH

LADENBURG THALM/SH SH lowered shares of Acrivon Therapeutics (NASDAQ:ACRV – Free Report) from a buy rating to a neutral rating in a research report report published on Monday morning, Marketbeat Ratings reports. Other equities analysts also recently issued research reports about the company. HC Wainwright reaffirmed a buy rating and issued a $20.00 price objective […]

Piper Sandler Increases Acrivon Therapeutics (NASDAQ:ACRV) Price Target to $30 00

Piper Sandler Increases Acrivon Therapeutics (NASDAQ:ACRV) Price Target to $30 00
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Acrivon Therapeutics (NASDAQ:ACRV) Given New $25 00 Price Target at BMO Capital Markets

Acrivon Therapeutics (NASDAQ:ACRV) Given New $25 00 Price Target at BMO Capital Markets
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.